| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,451 |
15,190 |
$904K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
8,146 |
5,667 |
$407K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,883 |
1,369 |
$156K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
2,854 |
1,991 |
$107K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12,207 |
8,514 |
$96K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,769 |
2,675 |
$74K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,137 |
987 |
$73K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14,644 |
8,527 |
$40K |
| 69210 |
|
1,975 |
1,503 |
$37K |
| 86318 |
|
3,606 |
2,583 |
$28K |
| 81025 |
|
5,133 |
3,604 |
$19K |
| 81002 |
|
9,933 |
7,092 |
$15K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
266 |
113 |
$13K |
| 86308 |
|
3,553 |
2,788 |
$12K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
330 |
267 |
$9K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
8,175 |
5,932 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
720 |
452 |
$5K |
| 97597 |
|
192 |
142 |
$4K |
| 99205 |
Prolong outpt/office vis |
26 |
26 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
208 |
177 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
9,170 |
6,705 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
912 |
751 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
180 |
129 |
$986.50 |
| 90756 |
|
91 |
84 |
$548.07 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
50 |
38 |
$520.30 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
109 |
57 |
$504.03 |
| 92551 |
|
67 |
62 |
$457.86 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
22 |
12 |
$383.67 |
| 82962 |
|
215 |
183 |
$343.44 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,808 |
1,805 |
$267.92 |
| 99173 |
|
90 |
74 |
$71.70 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
24 |
13 |
$68.95 |
| A7015 |
Aerosol mask, used with dme nebulizer |
168 |
122 |
$64.32 |
| 85018 |
|
67 |
49 |
$55.42 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
6,240 |
3,781 |
$53.08 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
22 |
14 |
$4.26 |
| 83037 |
|
61 |
44 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
88 |
29 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
204 |
126 |
$0.00 |